Trade Aytu BioScience, Inc. - AYTU CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.082 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023401% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001179% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.454 |
| Open | 1.494 |
| 1-Year Change | -47.87% |
| Day's Range | 1.494 - 1.494 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 24, 2024 | 1.454 | 0.050 | 3.56% | 1.404 | 1.484 | 1.404 |
| Dec 23, 2024 | 1.394 | 0.020 | 1.46% | 1.374 | 1.404 | 1.344 |
| Dec 20, 2024 | 1.334 | -0.010 | -0.74% | 1.344 | 1.404 | 1.324 |
| Dec 19, 2024 | 1.334 | 0.000 | 0.00% | 1.334 | 1.344 | 1.284 |
| Dec 18, 2024 | 1.324 | -0.070 | -5.02% | 1.394 | 1.394 | 1.294 |
| Dec 17, 2024 | 1.394 | 0.040 | 2.95% | 1.354 | 1.444 | 1.354 |
| Dec 16, 2024 | 1.374 | -0.020 | -1.43% | 1.394 | 1.414 | 1.344 |
| Dec 13, 2024 | 1.384 | -0.100 | -6.74% | 1.484 | 1.484 | 1.364 |
| Dec 12, 2024 | 1.454 | -0.110 | -7.03% | 1.564 | 1.564 | 1.454 |
| Dec 11, 2024 | 1.504 | -0.030 | -1.96% | 1.534 | 1.614 | 1.474 |
| Dec 10, 2024 | 1.594 | -0.080 | -4.78% | 1.674 | 1.724 | 1.514 |
| Dec 9, 2024 | 1.624 | -0.040 | -2.40% | 1.664 | 1.704 | 1.534 |
| Dec 6, 2024 | 1.614 | 0.110 | 7.31% | 1.504 | 1.694 | 1.474 |
| Dec 5, 2024 | 1.554 | 0.040 | 2.64% | 1.514 | 1.554 | 1.464 |
| Dec 4, 2024 | 1.544 | 0.010 | 0.65% | 1.534 | 1.584 | 1.504 |
| Dec 3, 2024 | 1.514 | -0.050 | -3.20% | 1.564 | 1.604 | 1.494 |
| Dec 2, 2024 | 1.594 | -0.050 | -3.04% | 1.644 | 1.644 | 1.564 |
| Nov 29, 2024 | 1.564 | 0.050 | 3.30% | 1.514 | 1.594 | 1.514 |
| Nov 27, 2024 | 1.584 | 0.170 | 12.02% | 1.414 | 1.594 | 1.414 |
| Nov 26, 2024 | 1.524 | -0.010 | -0.65% | 1.534 | 1.584 | 1.494 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Aytu BioScience, Inc. Company profile
About Aytu Biopharma Inc
Aytu Biopharma, Inc., formerly Aytu BioScience, Inc., is a specialty pharmaceutical company. The Company markets a portfolio of prescription products addressing primary care and pediatric markets. The Company's primary prescription products treat attention deficit hyperactivity disorder (ADHD) and other common pediatric conditions. It markets ADHD products Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets, Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets, and Adzenys-ER (amphetamine) extended-release oral suspension. The Company's other pediatric products include Karbinal ER (carbinoxamine maleate), an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary fluoride-based prescription vitamin product lines containing combinations of fluoride and vitamins in formulations for infants and children with fluoride deficiency.
Financial summary
BRIEF: For the six months ended 31 December 2021, Aytu Biopharma Inc revenues increased 57% to $45M. Net loss increased from $13.8M to $39.4M. Revenues reflect United States segment increase of 69% to $43.7M. Basic Earnings per Share excluding Extraordinary Items decreased from -$1.07 to -$1.53.
Equity composition
Common Stock no Par, 11/11, 30M auth., 4,774,568 issd. Insiders own 66.98%. 06/15, 1-for-12.174, Reverse Stock Split.
| Industry: | Pharmaceuticals (NEC) |
7900 E. Union Avenue
Suite 920
DENVER
COLORADO 80237
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com